Jeremy Udkoff

Jeremy Udkoff practices at Institute for Dermatopathology, Inc. in Pittsburgh, Pennsylvania.

Jeremy Udkoff's NPI, 1447756499, was assigned on March 30, 2018. Jeremy Udkoff holds Pennsylvania license MD478556.

Jeremy Udkoff's primary practice is Institute for Dermatopathology, Inc., at 875 Greentree Rd, Pittsburgh, PA 15220 in Allegheny County. The practice phone is (800) 845-3573.

Jeremy Udkoff's primary practice is Institute for Dermatopathology, Inc. in Pittsburgh, Pennsylvania. The medical group on file is Mt. Lebanon Dermatology Associates. Dmand AI also links Jeremy Udkoff to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jeremy Udkoff practices, 3 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Jeremy Udkoff's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dmand AI has Jeremy Udkoff's licenses on file in 2 states: Pennsylvania and New York.

CMS data shows 843 Medicare services from Jeremy Udkoff across 19 procedure codes in 2024, for 252 Medicare patients. Medicare paid $193,332 for them. Every service was in an office.

CMS counts 252 Medicare patients who saw Jeremy Udkoff in 2024. The largest group is 75 to 84, with 110 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Jeremy Udkoff's median patient age at 65, with 45% women.

In 2024, Jeremy Udkoff wrote 303 Medicare Part D claims for 200 patients. 99% of them were for generic drugs. CMS names the drug for 234 of them, across 8 drugs with 11 or more claims each, at $2,715 in total drug cost. In 2023, CMS named 22 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Jeremy Udkoff for performance year 2024, reported as part of a group. Jeremy Udkoff accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 76 procedures of melanoma (skin cancer) excision by Jeremy Udkoff, more than 91% of the clinicians it reports for that procedure.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Jeremy Udkoff, published from 2021 to 2023. 2022 was the busiest year, with 4. The most frequent topics are Skin Neoplasms, Diagnosis, Differential and Disease Progression. Jeremy Udkoff has published most often in J Am Acad Dermatol. Jeremy Udkoff's most frequent co-authors are David G. Brodland, MD, Lawrence F. Eichenfield, MD and Jusleen Ahluwalia, MD.

CMS Open Payments shows 20 general payments to Jeremy Udkoff from 9 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 88% of the total. Revance Therapeutics, Inc. paid the most, $274.